Charles M. Farber, PhD, MD

Atlantic Hematology Oncology, Morristown Medical Center, Morristown, NJ, USA
Atlantic Hematology Oncology, Carol G. Simon Cancer Center

n/a

Poster(s):

• 2009 - A phase 2 study of zanubrutinib in previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib: preliminary results for patients with CLL/SLL